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Abstract 
DOES MINIMALLY INVASIVE ROBOTIC SURGICAL TREATMENT ALTER 
EXERCISE TOLERANCE IN PATIENTS WITH ATRIAL FIBRILLATION AND 
MITRAL REGURGITATION AT SEVEN TO ELEVEN WEEKS POST-OPERATIVE? 
by Leena Jayesh Patel  
July, 2009 
Director: Timothy P. Gavin, Ph.D 
Department of Exercise and Sport Science 
In the current study, we examined if exercise tolerance was going to be reduced in atrial 
fibrillation and mitral valve regurgitation patients post a minimally invasive surgery 
seven to eleven weeks when compared to pre-operative.  Patients that participated in this 
study were diagnosed with atrial fibrillation or mitral valve regurgitation and were 
previously scheduled for minimally invasive corrective surgery.  Subjects were 
maximally stress tested over two visits, before and after surgery.  Oxygen consumption, 
maximal heart rate, and maximal treadmill time were measured.  They also filled out a 
Physical Activity Scale for the Elderly (PASE) before and after surgery to determine their 
activity levels.  A paired t-test with significance level set at P ≤ 0.05 revealed that 
exercise tolerance and activity levels were not found to be significantly different.  
Subjects in this study were found to be asymptomatic, had mild-moderate atrial 
fibrillation or mitral valve regurgitation, were younger than previously studied subjects 
and were active in their daily activities up until the day of their surgery.  The principle 
findings of this study are:  1) patients did not have reduced exercise tolerance after 
surgery when compared to pre-operative, 2) when compared to age predicted data, 
VO2MAX was not significantly different before or after surgery, and 3) there was no 
change in activity levels between pre and post surgery. 
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CHAPTER I 
INTRODUCTION 
The heart is one of the most important organs in the body.  Proper functioning of 
the circulatory system ensures a high quality of life.  When there are problems associated 
with the heart and its components, everyday activities become strenuous.  Atrial 
fibrillation (AF) and mitral valve regurgitation (MR) are two major types of dysfunctions 
that can severely lower an individual’s quality of life.
The prevalence of AF will increase as the elderly proportion of the population 
increases.  It has been projected that the number of Americans with AF will increase to 
more than 5.6 million during the next 50 years (Go, Hylek et al., 2001).  A more recent 
analysis has projected the number of adults with AF for the year 2050 to be 15.9 million, 
if a continuous rise in the incidence of AF persists (Miyasaka, Barnes et al., 2006).  As 
individuals age, the heart begins to lose function and efficiency.  When AF and MR are 
present concurrently, there is a significant decrease in an individual’s quality of life, 
functional status, and cardiac performance, as well as higher medical costs and a higher 
risk of death (Go, Hylek et al., 2001).  In many cases of AF and MR, surgical treatment is 
the only remaining option.  Robotically-assisted minimally invasive surgery can correct 
AF and MR returning the heart to sinus rhythm and cardiac unidirectional blood flow.  
Individuals in sinus rhythm have a higher quality of life and higher exercise tolerance 
than AF and MR patients.
The purpose of this study was to investigate if exercise tolerance was returned to 
pre-surgical capacity at 7-11 weeks post-robotic surgery to treat AF, MR and AF + MR.  
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Problem Statement
Currently it is not known if exercise tolerance can be restored in asymptomatic 
patients 7-11 weeks post robotic surgery.   
Hypothesis 
It was hypothesized that exercise tolerance would be reduced at 7-11 weeks post-
robotic surgery compared to pre-surgery in AF, MR and AF + MR patients.    
 
Delimitations: 
1) All subjects were men. 
2) Sample size of 4 subjects. 
3) Patients were not involved in a structured exercise program or participated in 30 
minutes of vigorous exercise per week in the last 2 months.   
4) All subjects were free of known pulmonary disease or any disease that would 
result in worsened exercise capacity independent of their cardiac disease. 
5) Atrial fibrillation and mitral valve regurgitation were diagnosed by physician.   
6) Patients were scheduled for AF or MR surgery. 
Limitations: 
1) Subjects may complete questionnaires, including the PASE and Modified Baeke, 
in a misleading or inaccurate manner. 
2) Failure of maximal effort during VO2MAX testing could lead to underestimation of 
exercise capacity workload and oxygen consumption.   
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Definition of Terms 
Exercise Capacity:  The maximum ability of the body to take up and use oxygen to do 
work 
Maximal Oxygen Consumption (VO2MAX): quantitatively expresses an individual’s 
capacity for aerobic energy production 
 
List of Acronyms 
AF:  Atrial Fibrillation 
MV:  Mitral Valve 
MVR:  Mitral Valve Regurgitation 
MR:  Mitral Regurgitation 
BMI:  Body Mass Index = body mass (kg) divided by height squared (kg/m2) 
PASE:  Physical Activity Scale for the Elderly 
NYHA:  New York Heart Association 
ECG:  Electrocardiogram 
HR:  Heart Rate 
BPM:  beats per minute 
TM:  Treadmill 
  
CHAPTER II 
REVIEW OF LITERATURE 
Normal Function of the Heart 
The primary function of the heart is to supply blood and nutrients.  In order for 
that to occur, a normal heart usually has a constant rhythm which beats between 60 to 
100 times a minute.   Athletes or highly trained individuals can have a resting rhythm as 
low as 40 beats per minute (bpm).  During each beat, or contraction, the heart expels 
blood into the aorta.  Each contraction is controlled by an electrical impulse traveling 
through the heart.  In the normal heart, these impulses occur at constant and regular 
intervals.  The rhythm of the heart is normally determined by a natural pacemaker called 
the sinoatrial (SA) node, which is located in the posterior wall of the right atrium near the 
superior vena cava.  The SA node spontaneously generates action potentials at rates of 
60-100 beats/minute (bpm).  This intrinsic rhythm is influenced by the autonomic nerves, 
with sympathetic stimulation accelerating the sinus node rate of depolarization and vagal 
stimulation slowing it (Malcolm S. Thaler, 2007).   
Sinus rhythm normally controls both the atrial and ventricular rhythm.  Action 
potentials generated by the SA node spread through the atria, depolarizing this tissue and 
in turn cause atrial contraction.  The impulse then travels into the ventricles via the 
atrioventricular node (AV node).  The purpose of the AV node is to provide a pathway 
for impulses from the atria to the ventricles (Malcolm S. Thaler, 2007).  There is a slight 
delay in conduction from the atria to ventricles, which allows the atria to contract first 
and the ventricles to fill with blood before the ventricles contract.  The impulse is then 
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picked up by specialized conduction pathways, bundle branches and Purkinje fibers, to 
rapidly conduct the wave of depolarization through the ventricles to produce a ventricular 
contraction.  Therefore, in a normal heart, the rhythm is controlled by the SA node.  
The heart consists of 4 chambers, right atrium, right ventricle, left atrium, and left 
ventricle.  The atriums are connected to the ventricles by valves.  Between the right 
atrium and right ventricle is the tricuspid valve and between the left atria and left 
ventricle is the mitral valve.  The right atrium collects de-oxygenated blood from the 
body (via the superior and inferior vena cava), pumps it through to the right ventricle via 
the tricuspid valve, and then pumps it through the pulmonary valve into the lungs.  
Oxygenated blood from the lungs then returns to the left atrium, pumps through the 
mitral valve into the left ventricle.  Blood is then pumped to the rest of the body via the 
aortic valve.  The muscle wall surrounding the left ventricle is thicker compared to the 
right ventricle due to the higher force needed to pump blood through the systemic 
circulation. 
Arrhythmias 
Variations in the heart rhythm are known as arrhythmias.  There are many types 
of arrhythmias and they are classified according to where they originate in the heart.  
Those that do not originate from the ventricles are generally called supraventricular 
arrhythmias while those originating from the ventricles are called ventricular arrhythmias 
(Malcolm S. Thaler, 2007).   Some general arrhythmias include supraventricular 
tachycardia, atrial flutter, ventricular tachycardia, and atrial fibrillation.  However, these 
are not the only arrhythmias, just the most common ones.   
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Supraventricular tachycardia occurs when the atria or the AV node produces a 
regular but rapid discharge.  The heart has a rate of over 100bpm (usually around 130-
150bpm).  Atrial flutter is generated by a reentrant circuit that runs largely around the 
annulus, the ring-like structure on a heart valve where the valve leaflets are anchored, of 
the tricuspid valve.  Atrial depolarization occurs at such a rapid rate that discrete P waves 
separated by a flat baseline are not observed (Malcolm S. Thaler, 2007).  Because the 
baseline continuously rises and falls, the effect produces a type of flutter wave.  The rate 
is usually fast (250-350 bpm) and irregular.  Ventricular tachycardia occurs when fast and 
regular impulses come from the ventricle and cause a very rapid heart rate.  This 
arrhythmia can be life-threatening and requires immediate medical attention.  Lastly, 
atrial fibrillation (AF), one of the most common chronic conditions (Benjamin, Wolf et 
al., 1998), is caused by electrical impulses discharged at a rapid rate from many different 
areas of the atria.  Unlike atrial flutter, where there is a single constant signal responsible 
for the flutter waves, in AF multiple reentrant circuits are unpredictably occurring  
(Malcolm S. Thaler, 2007).  In an ECG strip, no true P wave can be identified.  This 
arrhythmia also causes fast and irregular heartbeats (usually between 120-180bpm).         
Atrial Fibrillation 
Based on research conducted in 1995, an estimated 2.23 million Americans have 
AF, with a median age of  75 years (Feinberg, Blackshear et al., 1995).  The prevalence 
appears to double with each decade, from 0.5% in the population aged 50-59 years to 
almost 9% between ages 80-89 years, with prevalence being slightly higher in men than 
women (Conway, 2002) due to the decreased amount of estrogen found in men.  It has 
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been noted that men are 50% more likely than women to develop AF (Kannel, Wolf et 
al., 1998).  The incidence of AF increases with advancing age, with an annual incidence 
per 1000 person-years of about 3.1 cases in men and 1.9 cases in women 55 to 64 years; 
also rising to 38.0 and 31.4 cases in men and women 85 to 94 years of age (Benjamin, 
Levy et al., 1994).  
Basic features of AF are great rapidity of atrial depolarization, irregularity of 
atrial depolarization, and absence of regular atrial activity on the surface ECG (Gallagher 
and Camm, 1998).  Instead of one steady impulse, many impulses begin and spread 
through the atria to compete for a chance to travel to the AV node.  This causes a rapid 
and disorganized heartbeat.  Impulses in the atria can range from 300-600 bpm.  The AV 
node then tries to limit the number of impulses that travel to the ventricles.  Even before 
the ventricle has a chance to contract, another impulse may be sent.  Irregular ventricular 
activity is usually the result of AF, but is not necessary to identify it (Gallagher and 
Camm, 1998).       
There are known causes of atrial fibrillation but at times there can be no 
underlying heart disease.  The most common causes of AF are hypertension, coronary 
artery disease, valvular disease, congestive heart failure, cardiomyopathy, and congenital 
heart disease (Benjamin, Levy et al., 1994); however, atrial fibrillation can also develop 
after cardiac surgery (Benjamin, Wolf et al., 1998).  Obesity as a risk factor has been 
controversial in the past, but there is recent data suggesting an important risk relationship 
between BMI and AF development (Wang, Parise et al., 2004).  Non-cardiac etiological 
factors associated with atrial fibrillation include high alcohol intake, thyrotoxicosis, 
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diabetes, chronic obstructive lung disease, infection and pulmonary embolism (Conway, 
2002).  Also, atrial fibrillation may be related to excessive caffeine use, stress, illegal 
drugs, electrolyte, or metabolic imbalances (Kannel, Wolf et al., 1998).  In extreme cases, 
the cause is unknown.   
Atrial fibrillation can be diagnosed through several tests.  The most common tools 
used to diagnose AF include an electrocardiogram (ECG) or a holter monitor (24 hour 
test). An ECG records the electrical impulses traveling through the heart muscle.  The 
holter monitor is a small external recorder that is usually worn for one to three days.  This 
may be necessary because the condition often occurs sporadically.   
The echocardiographic risk factors for non-rheumatic AF include left atrial 
enlargement, increased left ventricular thickness, and reduced left ventricular factional 
shortening (Vaziri, Larson et al., 1994)  For each of these echocardiographic predictors, 
AF risk increases in a continuous graded fashion (Kannel, Wolf et al., 1998).  Because 
AF is usually associated with an underlying heart disease, other tests may need to be 
performed to fully diagnose the patient’s condition including coronary angiography, 
stress test, or nuclear imaging tests.      
Atrial fibrillation patients may be classified as acute or chronic, depending on 
whether the arrhythmia has been present for less than or more than 48 hours (Conway, 
2002).  Chronic AF can be further subdivided into paroxysmal (self-terminating and 
relapsing episodes), persistent (continuous episode, but susceptible to pharmacological or 
electrical cardioversion) and permanent (continuous AF despite attempts at 
cardioversion) (Conway, 2002).   AF is highly associated with morbidity and mortality 
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(Gillinov, 2007) because of further complications and consequences that can occur such 
as systemic thromboembolism, tachycardia-induced cardiomyopathy, significant 
symptoms, and poor quality of life (Ad, 2007).  Because the atria are beating rapidly and 
irregularly in chronic AF, blood does not flow quickly through them increasing the risk 
of a blood clot.  The clot can then be pumped out of the heart and travel to other parts of 
the body, such as the brain.   Circulating blood clots could result in a stroke.  Atrial 
fibrillation patients are five to seven more times likely to have a stroke (Conway, 2002; 
Savelieva and Camm, 2008).  Where most attributable stroke risk factors decline with 
advancing age, the attributable risks for stroke associated with AF increase with age, 
from 1.5% for those 50 to 59 years of age to 23.5% for those 80 to 89 years of age (Wolf, 
Abbott et al., 1991).  In patients between the ages 80-89, AF is the single most important 
independent risk factor for stroke (Conway, 2002).   
Because of the asynchronous electrical activity, there is a loss of atrial systolic 
function.  The loss of atrial systolic function results in a decrease in stroke volume of 
about 10% in normal individuals and a greater fall at fast ventricular rates because of the 
reduction in diastolic filling time (Conway, 2002).   Due to the decreased pumping ability 
of the heart, AF is an independent risk factor for increased mortality and it is also 
commonly associated with heart failure (HF) (Conway, 2002).  The prevalence of AF 
among patients with HF ranges from 10% to 30% (Crijns, Tjeerdsma et al., 2000).  AF is 
independently associated with a 50% to 90% increase in the risk of death in men and 
women consistently across the 4 decades of age studied (from 1948 to 1988) (Benjamin, 
Wolf et al., 1998).   
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Some patients have AF without any signs or symptoms, a condition known as 
silent AF.  If symptoms occur, they include but are not limited to heart palpitations, 
fatigue, shortness of breath, exercise intolerance, dizziness, angina, and syncope (Hamer, 
Blumenthal et al., 1994; Luderitz and Jung, 2000).  One study surveyed AF 147 patients 
and reported that 78% of patients had palpitations, 69% had fatigue, 68% had shortness 
of breath, 49% had exercise intolerance, 33% had dizziness, 29% had angina, and 14% 
had syncope (Jung and Luderitz, 1998).   
Treatments for AF can range from pharmacological to surgical.  Since there are 
intrinsic cardiac causes that predispose an individual to AF, simply decreasing the risk of 
cardiovascular events that induce AF will directly decrease the incidence of AF.  Rhythm 
and rate control medications can help return the heart to its normal sinus rhythm (Ad, 
2007; Savelieva and Camm, 2008).  However, side effects include increased risk of other 
arrhythmias.  Anticoagulants or antiplatelet therapy medications that are used to reduce 
the chance of blood clots and stroke can be contraindicated in the elderly because their 
use is often associated with significant morbidity (Kannel, Wolf et al., 1998).  Lifestyle 
changes can also be beneficial.  If a patient notices that certain activities trigger AF 
symptoms, such as smoking, then those activities should be limited and or avoided.  
Alcohol and caffeine should be taken in moderation if there is an excess usage or even 
better completely avoided.  Also stimulants in cough and cold medications can promote 
irregular heart rhythms. 
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Mitral Valve Regurgitation 
Atrial fibrillation is sometimes combined with other problems.  One of the 
common problems associated with AF is mitral valvular disease or mitral regurgitation 
(MR) (Howes, Reid et al., 2001; Gillinov, 2007; Parthenakis, Patrianakos et al., 2007).  
The mitral valve permits the flow of blood from the atrium to the ventricle during 
ventricular diastole and prevents retrograde flow during ventricular systole.  The mitral 
valve consists of valvar leaflets, the annulus, tendinous cords/papillary muscles, and 
subvalvar apparatus.  The mitral valvar complex also includes the left atrial and left 
ventricle myocardium, left atrial and left ventricle endocardium, and the aorto-mitral 
curtain (Muresian, 2008).  The mitral valve uses the tight systolic closure of the left 
atrioventricular orifice to prevent backflow of the blood from the left ventricle into the 
atrium.  As blood fills the left atrium, the mitral valve remains closed until adequate 
pressure is generated to open the valve.  The valve permissively allows for the atria to 
rapidly, forcefully, and efficiently eject the blood into the left ventricle and then the aortic 
root (Muresian, 2008).  
Normally, the mitral valve opens due to pressure allowing blood to flow into the 
left ventricle during left atria systole.  It closes at the end of atrial contraction to prevent 
blood from back flowing into the atria during left ventricular systole.   
The mitral valve has two leaflets that guard the opening.  The opening is 
surrounded by a fibrous ring known as the mitral valve annulus.  These leaflets are 
prevented from prolapsing into the left atrium by the tendons attached to the posterior 
surface of the valve, chordae tendineae.  The chordae tendineae are attached at one end to 
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the papillary muscles and the other to the valve cusps.  When the left ventricle contracts, 
the intraventricular pressure forces the valve to close and prevent blood from flowing 
back into the left atria.  During this time, the tendons prevent the valve from opening in 
the wrong directions.  This prevents blood from flowing back to the left atrium.  If 
damage occurs to any part of the mitral valvar complex, it can hamper emptying of the 
left atrium, incompetence of the mitral valvar, and/or ejection of the left ventricle 
(Muresian, 2008).   
Mitral regurgitation (MR) is the second most common valve disease, representing 
nearly one-third of acquired left-sided valve disease (Iung, Baron et al., 2003).  Mitral 
regurgitation is defined as a disorder in which the heart’s mitral valve does not properly 
close, causing blood to flow backward into the upper heart chamber.  This causes a 
decrease in forward blood flow, which in turn through negative feedback increases the 
forces of cardiac contraction (Libby, 2007).  The main causes of mitral regurgitation 
include myxomatous (degeneration of the mitral valve), ischemic heart disease, coronary 
artery disease, and Rheumatic heart disease along with several others.  Mitral 
regurgitation may also be caused by dysfunction or injury to the valve following a heart 
attack or infection of the heart valve (infective endocarditis) which may rupture the valve 
or surrounding structures, leaving an opening for blood to move backwards (Libby, 
2007).  The most common cause of mitral regurgitation is myxomatous degeneration of 
the valve.  Degeneration is more common in males and with advancing age.  There is a 
defect in the collagen that makes up the mitral valve which causes the leaflets and 
chordae tendineae to become stretched out.  The stretched out valve leaflets and chordae 
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tendineae prevent the valve leaflets from closing properly, causing the valve leaflets to 
prolapse into the left atrium causing mitral regurgitation.   The most common scenario 
that involved both MR and AF is found in rheumatic disease (Gillinov, 2007).   
It is important to distinguish between primary and secondary (functional) MR.  In 
primary MR, abnormalities of one or more components of the mitral valve cause it to leak 
and permit backflow which in turn results in left ventricular volume overload (Carabello, 
2008).  Severe prolonged primary MR can result in left ventricular remodeling, 
myocardial dysfunction, pulmonary hypertension, heart failure, and death.  Correction of 
primary MR in a timely fashion can help to prevent these effects.  In secondary MR, a 
damaged left ventricle causes the mitral valve to leak and as a result makes it harder to 
treat secondary MR (Carabello, 2008).  In secondary MR, myocardial damage causes a 
normal valve to leak, so even if MR is corrected, the underlying muscle disease will still 
persist (Carabello, 2008).   
Mitral regurgitation can become a chronic condition.  Symptoms include but are 
not limited to chest pain, cough, rapid breathing, orthopnea, palpitations, fatigue, and 
light-headedness (Libby, 2007).  People with mild to moderate chronic mitral valve 
regurgitation may be asymptomatic.  Even moderate to severe disease may never display 
symptoms.  If the heart weakens because of the mitral valve, symptoms of heart failure 
will occur: shortness of breath with activity, extreme tiredness and weakness, and/or 
edema.  Acute mitral valve regurgitation is an emergency, causing severe shortness of 
breath at rest, coughing, and fast heart beat.  
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MR imposes a volume overload in the left ventricle (LV), but unlike aortic 
regurgitation, it does not cause an increase in systolic blood pressure (Wisenbaugh, 
Spann et al., 1984).  Because of increased LV volume from MR, total stroke volume 
increases, and the resulting thin left ventricular wall enhances diastolic filling (Carabello, 
2008).  In acute MR, afterload is actually decreased; in chronic compensated MR 
afterload is normal, and in chronic decompensated MR afterload may actually be greater 
than normal (Corin, Monrad et al., 1987).  If the damaged mitral valve is replaced, where 
some or all of the chordal attachments between the papillary muscles and valve leaflets 
are maintained, it can help preserve left ventricular function and improves exercise 
capacity (David, Burns et al., 1984; Madaric, Watripont et al., 2007).   
To diagnose mitral valve regurgitation, one of the simplest ways is for a doctor to 
feel for a thrill (vibration) over the heart when feeling the chest area (Libby, 2007).  
While listening to the heart, an extra heart sound (S4 gallop) and a distinctive heart 
murmur may be heard (Libby, 2007).  If fluid backs up in the lungs, crackles may be 
heard.  Diagnostic tests include a chest x-ray, CT scan of the chest, ECG, 
echocardiogram, or a cardiac catheterization.  Treatment depends on the severity of the 
condition symptoms.  Antibiotics are prescribed for bacterial infection and to reduce the 
risk of infective endocarditis.  Anti-hypertensive drugs and vasodilators reduce the strain 
on the heart.  Anti-coagulants or anti-platelet medications prevent clot formation in 
patients that also have AF.  Digitalis may be used to strengthen the heartbeat, and along 
with diuretics, remove excess fluid in the lungs (Libby, 2007).  Patients with severe 
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symptoms may need to be admitted to a hospital for treatment, and for severe leakages 
emergency surgery may be necessary.   
Exercise Capacity and Exercise Tolerance 
Exercise is a physiological stress that in turn stresses the cardiovascular system.  
In the healthy population, heart rate (HR) and systolic arterial pressure (SAP) increase 
during exercise.  Patients with AF fatigue rapidly and experience palpitations more 
frequently due to exertion.  Gas exchange measurement for the determination of maximal 
oxygen consumption (VO2MAX), as assessed during cardiopulmonary exercise testing, has 
become widely established in the routine evaluation and in risk stratification of patients.  
At sub maximal exercise levels, HR in patients with AF increases more than in those with 
sinus rhythm (Ueshima, Myers et al., 1993; Howes, Reid et al., 2001).  Exercise tests in 
AF patients are performed predominantly in order to determine if the ventricular rate is 
under control by pharmacological treatment, to determine functional capacity, and to plan 
rehabilitation programs (Ueshima, Myers et al., 1993).   
In patients with MR, echocardiographic findings at rest, such as systolic and 
diastolic left ventricular dimension, do not accurately reflect a patient’s functional status 
or symptoms (Enriquez-Sarano, Tajik et al., 1994).  Cardiopulmonary exercise testing is 
considered the standard tool for evaluating functional status, especially in AF and MR 
patients.  Poor exercise capacity, reflected by a low peak oxygen consumption (peak 
VO2) paired with an increased ventilatory response as indicated by a steeper slope of 
ventilation to carbon dioxide production rate (VE/VCO2 slope), are strong unfavorable 
predictors of outcome (De Feo, Franceschini et al., 2005).   
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Patients with AF have a significantly reduced exercise capacity (Agostoni, Emdin 
et al., 2008).  One of the major characteristics of AF that decreases exercise performance 
is the irregular, rapid ventricular response at rest and during exercise which may reduce 
cardiac output by 10% or more (Vanhees, Schepers et al., 2000).  Cardiac patients with 
concomitant AF may derive less benefit from traditional cardiac rehabilitation than other 
cardiac patients because of their greater reduction in exercise tolerance related to AF.  
Improving exercise tolerance is very important for these patients because their exercise 
capacity can be reduced from 15-20% (Atwood, Myers et al., 2007).  At anaerobic 
ventilator threshold, AF patients have a higher VO2 and heart rate, while sinus rhythm 
patients have a higher peak exercise VO2, O2 saturation, and work load (Agostoni, Emdin 
et al., 2008).  The reasoning for a lower VO2 at peak but higher VO2 at anaerobic 
threshold is likely related to the higher chronotropic response to exercise in AF patients 
likely due to an increased sympathetic drive activated to maintain cardiac output.  
Agostini et al. did not measure cardiac output during exercise; since O2 saturation was 
lower, they argued it was likely that stroke volume was lower at peak exercise in AF 
patients.  Despite the reduction in exercise tolerance, AF patients demonstrate similar 
increases in VO2MAX compared to controls (Vanhees, Schepers et al., 2000).  In addition 
to improvements in exercise tolerance, exercise training also is associated with improved 
overall emotional health (Hegbom, Sire et al., 2006).  Interestingly, men demonstrate 
greater improvements in peak VO2 and peak cardiac output with exercise training than 
women (Mertens and Kavanagh, 1996). 
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The heart is a muscle and like any muscle, it gets stronger with exercise. Aerobic 
exercise strengthens the heart and makes it more efficient and is generally recommended 
for those with mitral valve regurgitation.  Studies have shown that AF patients who 
engage in regular aerobic exercise report a decline in symptoms of chest pain, fatigue, 
dizziness and mood swings, and panic attacks (Bonow, Carabello et al., 2006).  A person 
with mitral valve regurgitation should monitor their heart rate and other symptoms and 
slow down if they feel their heart racing, become lightheaded, or faint.  
Mitral valve regurgitation is generally not considered to be a life threatening or a 
progressive condition.  It may be the most benign of the various types of heart murmurs. 
However, over time, the added workload on the heart may cause shortness of breath with 
exercise or it may cause an abnormal heart rhythm (Bonow, Carabello et al., 2006). The 
abnormal rhythm feels like your heart is pounding, racing, or skipping in your chest.  If a 
valve leaflet cord breaks, the sudden regurgitation may quickly cause heart failure.  There 
are cases where even mild mitral valve regurgitation poses significant health problems 
and in these cases valve replacement would be considered.  
Surgical Treatment 
If medications are ineffective or not well tolerated by AF or MR patients, then 
more aggressive treatment would be required.  Non-pharmacological approaches are 
usually offered to symptomatic patients, and can be done either by percutaneous catheter 
techniques or various surgical approaches (Ad, 2007).  Procedures such as electrical 
cardioversion, catheter ablation, pulmonary vein isolation, or ablation of the AV node are 
the most common procedures performed.  If these procedures are unsuccessful, even 
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more aggressive treatments may be necessary.  Usually surgery is recommended for 
patients with chronic AF and MR since their symptoms cannot be relieved by 
medications or any other procedures.  There are a few options for surgical treatment as 
well, but the most widely used are the robotically assisted minimally invasive mitral 
valve repair with the atrial cryo-maze procedure.   
The original Cox-Maze procedure was developed by James Cox in 1987 to treat 
the atrial fibrillation and restore the atria to a more normal atria (Cox, 1991).  Since then 
a series of improvements have been made, resulting in the Cox maze III procedure.  Cox 
Maze III is associated with a higher incidence of sinus rhythm return, improved long-
term sinus node function, fewer pacemaker implantations, and improved long-term atrial 
transport function (Ad 2007).  Now considered the “gold standard,” Cox-Maze III is also 
technically less demanding than the Cox-Maze I and II procedures.  During the 
procedure, a series of precise incisions are made in the right and left atria to interrupt the 
conduction of abnormal impulses (Cox, Jaquiss et al., 1995; Gillinov, 2007).  A “maze” 
of new electrical pathways is created to allow electrical impulses to travel easily through 
the heart.  This allows for a more normal sinus impulse to reach the AV node.  A recent 
report demonstrated long-term results in patients having the Cox-Maze III procedure, 
either as an isolated or a combined procedure, with a success rate greater than 95% 
(Damiano, Gaynor et al., 2003; Prasad, Maniar et al., 2003).   Another important impact 
of the Cox-Maze III procedure is a reduction in the rate of cerebrovascular accidents and 
transient ischemic events (Ad, 2007; Gillinov, 2007).  There have been numerous 
revisions to the Cox-Maze III which have reduced the complexity of the procedure, but in 
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turn have sacrificed the completeness of the procedure and produced questionable 
outcomes (Kiser, Wimmer-Greinecker et al., 2007).  According to Kiser et al. (2007), the 
best treatment for all types of atrial fibrillation remains the full Cox-Maze III, which 
addresses both the left and right atria; and is also associated with clinical benefits in 
patients with mitral valve disease (Gillinov, 2007).   
Originally the Cox Maze procedure used the standard cut-and-sew method.  Now 
there are a variety of devices that use different energy sources that permits the surgeon to 
rapidly perform corrective AF with very few suture lines (Gammie, Didolkar et al., 
2009).  One of the new methods uses argon-powered cryoenergy and is known as 
CryoMaze.  As a treatment for atrial fibrillation, the CryoMaze procedure creates linear 
cyolesions (frozen scars) in the upper chamber of the heart by applying an argon-powered 
cold probe to freeze the tissue (Gammie, Laschinger et al., 2005).  Freezing the tissue 
creates electrical barriers, which permanently block electrical activity, thus correcting for 
AF.  Electrical barriers can be created in 60-90 seconds, minimizing the duration of the 
procedure.  It has been suggested to be safer and more efficient for the treatment of AF 
(Gammie, Laschinger et al., 2005) or when combined with other cardiac operations 
(Gammie, Didolkar et al., 2009).  Associated with the CryoMaze are lower stroke rates in 
long-term follow-up and results that are equivalent to those of the classic Cox Maze III 
(Gammie, Laschinger et al., 2005).  Compared with other energy sources, collateral 
injury has never been reported, there is a long track record of safety, there is a greater 
likelihood of a contiguous lesion, and cryotherapy is associated with a lower endocardial 
thrombus volume (Gammie, Laschinger et al., 2005; Gammie, Didolkar et al., 2009).   
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With surgery time being reduced, recovery duration is the next stage.  Minimally 
invasive mitral valve surgery continues to evolve as a treatment option.  Studies have 
been conducted showing that mitral valve procedures could be performed with a small 
incision by modifying the standard sternotomy, or open chest method (Cohn, Adams et 
al., 1997; Cosgrove, Sabik et al., 1998).  These studies have also reported large and 
successful series of endoscopic mitral valve repairs using various systems.  But with the 
da Vinci® Robotic system, many of the concerns of minimally invasive mitral valve 
repair were addressed.  The da Vinci® Robotic system allows three-dimensional 
visualization of the operative field and improved surgical manipulation by the use of the 
endowrists of the surgical arms (Tatooles, Pappas et al., 2004).  With the introduction of 
the transthoracic aortic cross clamp and the da Vinci® Surgical System, mitral valve 
repair can be performed in the same manner as the standard sternotomy but with truly 
limited incisions (Tatooles, Pappas et al., 2004).  Advantages of minimally invasive 
mitral valve surgery are reduced surgical trauma, decreased pain, fewer complications, 
improved cosmesis, shorter length of stay, less bleeding and fewer pulmonary 
complications, and earlier return to normal daily activity for the patient (Mohr, Onnasch 
et al., 1999; Reichenspurner, Boehm et al., 2000; Felger, Chitwood et al., 2001; 
Casselman, Van Slycke et al., 2003; Tatooles, Pappas et al., 2004).         
On the day of surgery, electrodes are placed on the patient’s chest.  The electrodes 
are connected to an electrocardiogram machine which monitors the patient’s heart rhythm 
and electrical activity.  For the original procedure, the surgeons make an incision down 
the center of the chest and then split the breastbone.  This facilitates complete 
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visualization of the heart and reduces the number of complications.  However, using the 
Robotic-Assisted Maze surgery only small incisions are made between the ribs.  The 
surgeon uses video guided instruments to manipulate a catheter and perform the 
ablations.  The catheter directs cryo-freeze energy to the precise areas in the heart tissue 
to create lesions that block erratic electrical signals from traveling through the heart (Cox, 
Jaquiss et al., 1995; Savelieva and Camm, 2008).  The patterns of the incision resemble a 
maze, which directs the heart’s electrical impulses straight to the heart’s lower chambers 
due to scar tissue that forms.  The scar tissue cannot carry electrical impulses and thus 
creates a barrier to keep the electrical impulses on course.   
Surgical correction of MR aims to preserve cardiac function and to improve 
function status and survival (Le Tourneau, de Groote et al., 2000).  Chronic MR results in 
a progressive deterioration in left ventricle (LV) contractile function, although the LV 
ejection fraction (EF) is maintained over a relatively long period (Starling, 1995).  After 
mitral valve surgery, LV contractile impairment has the ability to recover towards normal 
in most patients.   
Exercise tolerance after surgery  
In AF patients, Cox Maze does appear to effectively prevent exercise-induced AF 
(Hemels, Gu et al., 2006).  In patients in whom sinus rhythm was established by Cox-
Maze, exercise-induced initiation of AF was not observed.   
Exercise capacity of patients with and without heart disease that underwent the 
Cox Maze procedure combined with mitral valve surgery do experience improvements in 
exercise tolerance in the late phase of their recovery hypothesized to occur through the 
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restoration of sinus rhythm (Yuda, Nakatani et al., 2004).  Mitral valve surgery can 
improve exercise tolerance independent of sinus rhythm abnormalities (Le Tourneau, de 
Groote et al., 2000), though not all studies demonstrate such an effect (Kim, Ahn et al., 
2004). 
The proper timing of surgery in asymptomatic patients remains controversial 
(Madaric, Watripont et al., 2007).  Usually, surgery was proposed when patients started 
having symptoms.  However, it has been shown that patients operated on before the 
occurrence of symptoms have a better survival than patients operated on with severe 
symptoms  (Enriquez-Sarano, Tajik et al., 1994; Tribouilloy, Enriquez-Sarano et al., 
1999).  Currently the effect of mitral valve repair (MVR) on exercise capacity and 
cardiopulmonary testing in patients with little or no symptoms is relatively unknown; 
however, studies have attempted to understand the mitral valve healing duration post 
surgery to better access those effects.   
One study looked at exercise tolerance 6 months after surgery and showed no 
change in exercise tolerance despite the mitral regurgitation correction, in absence of 
exercise reconditioning (Le Tourneau, de Groote et al., 2000).  It is well known that 
physical training improves exercise performance in patients with coronary heart disease 
(Hambrecht, Walther et al. 2004) and heart failure (Belardinelli, Georgiou et al., 1999), 
but it is not known how long it takes for the mitral valve to heal after mitral regurgitation 
surgery in humans.  Meurin et al. (2005) evaluated the safety and feasibility of early 
exercise training in patients after mitral valve repair.  The 251 subjects were placed in an 
exercise training program that included calisthenics and endurance bicycle training for 
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about 8 weeks.  Exercise training increased both peak VO2 (22% increase) and anaerobic 
threshold (16% increase) (Meurin, Iliou et al., 2005).  Exercise training appears to be safe 
in this population, does not have adverse effects on mitral valve function, and improves 
exercise tolerance.    
Madaric et al. (2007) assessed the changes in cardiopulmonary functional 
capacity after minimally invasive video-assisted mitral valve repair in patients with mitral 
regurgitation with mild to no symptoms.  All patients were in sinus rhythm and had a 
normal ejection fraction, and 80% claimed to be completely asymptomatic.  They focused 
on testing patients one week before surgery and 4 months after surgery and were tested 
using a ramp protocol.  The patients’ quality of life was also assessed during testing time 
by the Euro Quality of life (EuroQol) questionnaire (Dolan, 1997).  The questionnaire 
was composed of 5 items:  mobility, self-care, usual activity, pain or discomfort, and 
anxiety or depression.  Four months after surgery they found significant improvements in 
VO2MAX, maximal workload, and peak oxygen pulse.  Patients increased their overall 
health status also.  They concluded their study stating that the minimally invasive repair 
improves exercise capacity of patients with severe mitral regurgitation with none to mild 
symptoms.   
Conclusion 
 Aging increases the risk of developing AF and MR, both which decrease exercise 
capacity and exercise tolerance.  It is imperative to examine exercise capacity post 
surgery to gain a better understanding of how quickly patients can return to normal daily 
activity and improvements in exercise capacity.  There is no documented evidence 
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examining the exercise capacity in patients 7-11 weeks post surgery.  The aim of this 
study is to measure the patients’ VO2MAX pre and 7-11 weeks post surgery to see if there 
is a difference in exercise tolerance.  Insight into exercise tolerance changes 7-11 weeks 
post surgery can lead to quicker return to daily activity and ability to increase exercise 
capacity post surgery. 
  
  
CHAPTER III 
METHODS 
Prior to testing, approval of methods was given by the University and Medical 
Center Institutional Review Board, and conformed to the University, State of North 
Carolina, and Federal mandates for standard operating procedures (Appendix A). 
Subjects 
 Subjects diagnosed and already scheduled for treatment of AF, MR or AF+MR by 
minimally invasive surgery were recruited by their physician.  Any patient who was 
involved in a structured exercise program or participated in 30 minutes of vigorous 
exercise per week in the last 2 months was excluded.  Also any other medical conditions 
that would prevent patients from safely participating in this study or would result in 
worsened exercise capacity independent of their cardiac disease were excluded.  Once 
participants were selected they had the following procedures performed before and 7-11 
weeks post-surgery.  Four male subjects volunteered for this study (mean age 57 years).   
Testing Protocol 
The testing of these patients was covered over two visits.  All testing was 
performed at Brody room 3S08.  After informed consent was signed, on each testing day 
Physical Activity Scale for the Elderly (PASE) questionnaire and the Modified Baeke 
(Appendix C) was filled out by one on one interview, resting vitals were measured 
(height, weight, resting blood pressure, and resting heart rate), minimum waist 
circumference, and percent body fat was measured by skin folds.  Skin fold locations 
include chest, axilla, triceps, subscapular, abdominal, suprailium, and thigh.  All 
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measurements were done on the right side of the body and performed twice, three times if 
there is a more then 2 mm discrepancy in measurements.   
The questionnaire was used to quantify the amount of activity each individual did 
before and after surgery.  PASE questionnaire was used because it closely matched the 
literature for how patients function ability was with their condition.  Patients were 
compared to themselves regarding changes in activity levels pre and post-surgery.       
Following the resting measurements, subjects performed a physician supervised, 
symptom limited, graded exercise test using the Modified Naughton treadmill test (Table 
1) for determination of maximal oxygen consumption (VO2MAX).  Exercise intensity 
increased while minute ventilation, inhaled oxygen and exhaled carbon dioxide 
concentrations of the subject were continuously monitored via ParvoMedics TrueMax 
2400 Metabolic Cart (Consentius Technologies, Sandy, UT).  VO2MAX is the maximum 
capacity of an individual’s body to transport and utilize oxygen during incremental 
exercise, which reflects the physical fitness of the individual.  VO2MAX is reached when 
oxygen consumption remains at steady state despite an increase in workload.  Prior to and 
during exercise, subjects had their blood pressure measured and a 12-lead ECG 
monitored.  Heart rate was monitored continuously and recorded every two minutes using 
a Polar Electro heart rate monitor (Polar Electro, Washington, NY).  Subjects were 
encouraged to continue as long as possible.  The exercise test was stopped if the subject 
felt dizzy, had chest pain, had serious shortness of breath, or verbally indicated they 
wanted the test to be ended.  If the physician detected an abnormal heart function from 
the ECG, then the test was terminated.  At the end maximum time was recorded.   
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Statistical Analysis 
 A paired t-test was used to determine differences in VO2MAX pre- and post-surgery 
in between individuals.  Significance was established at P ≤ 0.05 and data reported are 
Mean ± SE.   
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Table 1:  Modified Naughton Treadmill Protocol 
 
Time (min) Stage Speed (mph) Grade (%) 
0-2 1 1.0 0 
2-4 2 1.5 0 
4-6 3 2.0 3.5 
6-8 4 2.0 7.0 
8-10 5 2.0 10.5 
10-12 6 3.0 7.5 
12-14 7 3.0 10.0 
14-16 8 3.0 12.5 
16-18 9 3.0 15.0 
18-20 10 3.5 15.0 
 
 
Time (min), time in minutes of the treadmill test.  Speed (mph), speed, measured in miles 
per hour, for each stage.  Grade (%), percent incline for each stage.   
  
CHAPTER IV 
RESULTS 
Subject Characteristics  
Subject characteristics are in Table 2.  Four male patients completed both the pre- 
and post-surgery exercise testing.  Mitral valve disease was present in all patients and 
surgical repair was performed.  One patient had combined MR and AF and also had the 
biatrial cryo-maze procedure performed.  All patients had the minimally invasive robotic 
surgery performed.  There were no differences in HR, % body fat, waist circumference, 
or treadmill time pre and post-operative (Table 4). 
Exercise Tolerance 
There was no change in exercise tolerance pre vs. 7-11 weeks post-operation, 
therefore showing that patients did not have a reduced exercise capacity after surgery 
(Table 4).  Subjects also showed no significant changes in their activitity levels, treadmill 
time to exhaustion and HR pre and post surgery (Table 4).  When compared to Houmard 
et al.’s (1998) age predicted data, the subjects’ VO2MAX were not significantly different 
before or after surgery (Figure 1).  However, when compared to ACSM age predicted 
VO2MAX, subject’s had a significantly lower post-surgery VO2MAX  (Medicine, 2005) 
(Figure 2). 
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Table 2: NYHA Classification 
 
Class Patient Symptoms Patients 
      
Class I (Mild) No limitation of physical activity.  4 
  Ordinary physical activity does not cause    
  undue fatigue, palpitation, or dyspnea   
  (shortness of breath).   
      
Class II (Mild) Slight limitation of physical activity.  0 
  Comfortable at rest, but ordinary physical    
  activity results in fatigue, palpitation, or dyspnea.   
      
Class III 
(Moderate) Marked limitation of physical activity.  0 
  Comfortable at rest, but less than ordinary    
  activity causes fatigue, palpitation, or dyspnea.   
      
Class IV (Severe) Unable to carry out any physical activity 0 
  without discomfort. Symptoms of cardiac   
  insufficiency at rest. If any physical activity   
  is undertaken, discomfort is increased.   
 
 
In order to determine the best course of therapy, physicians often assess the stage of heart 
failure according to the New York Heart Association (NYHA) functional classification 
system. This system relates symptoms to everyday activities and the patient's quality of 
life.   
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Table 3:  Individual Data Pre and Post surgery 
 
Record Age Pre % Fat Height Weight Waist TM Time Max HR Pre-VO2MAX Pre-VO2MAX 
Number (yrs) (%) (cm) (kg) (cm) (min) (bpm) (L/min) (mL/kg/min) 
MR001 59 N/A 175.3 75.9 n/a 20:00 189 2.21 29.1 
MR002 49 24.2 172.7 89.5 98.0 13:40 149 2.04 22.7 
MR003 64 18.4 188.0 78.6 94.0 12:36 157 1.89 24.1 
MR005 56 20.5 170.2 84.5 100.3 21:10 164 2.91 34.5 
                    
Record Age Post % Fat Height Weight Waist TM Time Max HR Post-VO2MAX Post-VO2MAX 
Number (yrs) (%) (cm) (kg) (cm) (min) (bpm) (L/min) (mL/kg/min) 
MR001 59 24.8 175.3 72.1 97.8 19:22 180 2.12 28.0 
MR002 49 26.1 172.7 90 97.8 15:24 167 2.15 23.9 
MR003 64 18.7 188.0 77.5 92.2 12:42 150 1.68 21.7 
MR005 56 27.6 170.2 84.5 101.6 15:40 110 2.14 25.3 
 
% Fat, percentage body fat taken using 7 site skin folds on the right side of the subject 
pre- and post-operation.  TM, Treadmill time to maximum exercise.  Max HR, heart rate 
at maximum exercise.  VO2MAX, maximal oxygen consumption.   
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Table 4:  Demographic and Exercise Data 
 
  Pre-Op Post-Op P Value 
Age, yrs 57 ± 3 
  
Height, cm 176.0 ± 4.3 
  Mass, kg 82.2 ± 3.1 81.1 ± 3.9 0.321 
Waist, cm 97.5 ± 1.5 97.3 ± 2.0 0.762 
%BF 21.0 ± 1.5 24.3 ± 1.9 0.520 
PASE Scores 255 ± 100 194 ± 103 0.171 
TM time, sec 1012 ± 131 947 ± 82 0.539 
Max HR, bpm 164.8 ± 8.6 151.8 ± 15.2 0.449 
Absolute VO2MAX, (L/min) 2.26 ± 0.23 2.023 ± 0.11 0.293 
 
 
Pre (Pre-Op) and post-operative (Post-Op) data.  %BF, percentage body fat.  PASE 
Scores, Physical Activity Scale for the Elderly.  TM time, maximum treadmill time to 
exhaustion.  Max HR, heart rate at maximum exercise.  VO2MAX, absolute maximal 
oxygen consumption.  * - significantly different (p ≤ 0.05). Mean ±SE.   
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Relative VO2MAX 
Pre and Post-operation  
Compared to age predicted data 
 
Pre-Op Post-Op Age Predicted
0
10
20
30
40
VO
2m
ax
 
(m
L/
kg
/m
in
)
  
 
Figure 1:  Relative VO2MAX pre (Pre-Op) and post-operative (Post-Op)  and age 
predicted (Houmard, Weidner et al. 1998).  One way repeated measures Anova was used 
to analyze relative VO2MAX pre (Pre-Op) and post-operative (Post-Op) and age predicted 
data (Houmard, Weidner et al. 1998).  There were no significant differences in relative 
VO2MAX between Pre-Op, Post-Op, or Age Predicted.  # - significant difference between 
groups. Mean ±SE.   
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Relative VO2MAX 
Pre and Post-operation  
Compared to ACSM data 
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Figure 2:  Relative pre (Pre-Op) and post-operative (Post-Op)VO2MAX values compared 
to ACSM age predicted (Medicine 2005).  One way repeated measures Anova was used 
to analyze relative VO2MAX pre (Pre-Op) and post-operative (Post-Op) and ACSM age 
predicted data (Medicine 2005).  ACSM age predicted VO2MAX was found to be 
significantly higher than post-operative values.  # - significantly different than all other 
groups (p ≤ 0.05). Mean ±SE.  
  
CHAPTER V 
DISCUSSION 
Findings 
The principle findings of this study are:  1) patients did not have reduced exercise 
tolerance after surgery when compared to pre-operative, 2) when compared to age 
predicted data (Houmard, Weidner et al. 1998), VO2MAX was not significantly different 
before or after surgery (Figure 1), and 3) there was no change in activity levels between 
pre and post surgery (Table 4).  The findings of the current study do not support the 
hypothesis that exercise tolerance would be reduced 7-11 weeks post-operation. 
Subject Characteristics     
 Patients were recruited by their physician and in this study were asymptomatic 
and functional in their daily living up until the day of surgery.  The NHYA 
classifications, which are a functional and therapeutic classification for prescription of 
physical activity for cardiac patients, showed the subjects were not in a severe condition.  
All four patients were NHYA I classified, meaning they had no limitation of physical 
activity and ordinary physical activity does not cause undue fatigue, palpitation, or 
dyspnea (shortness of breath).  They were not assisted in their daily living, those that 
worked still went to work, and their daily activities were not affected by their heart 
condition.   
Patients came in one week to as little as 3 days before their surgery.  Patients are 
not seen far in advance before surgery and get surgical treatment soon after their first 
exercise visit.  Their post-operation stress test was done at approximately 7-11 weeks 
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post-op, usually during their follow-up with the surgeon.  Unlike previous studies that 
tested severely de-conditioned patients who were unable to perform their daily activities, 
the patients in the current study were completely functional and were younger (mean age 
57 ± 3 compared to studies with mean ages of 70+).  The current study specifically tested 
patients that were not severely de-conditioned and had a very good NYHA classification.  
Another study, that investigated severely de-conditioned patients who were unable to 
perform their daily activities, showed that after surgery their activities levels did increase 
and they were able to perform majority of their daily activities without fatigue (Le 
Tourneau, de Groote et al., 2000).   
 Given that the current patients were sedentary post-operation and still healing 
from surgery, their exercise capacity did not drop significantly from pre-operations 
values.  When compared to Houmard et. al’s (1998) age predicted data, there was no 
significant difference.  The subjects’ VO2MAX were closer to Houmard et. al’s (1998) age-
predicted data then when compared to ACSM’s age predicted VO2MAX.  This is due to the 
fact that as an individual ages, their VO2MAX decreases linearly and a prediction that takes 
that into account is more accurate.  ACSM’s data classifies individuals based on a 10 year 
age predicted VO2MAX (Medicine 2005).   A 50 year old male’s VO2MAX will not be the 
same when he turns 59 years old and thus cannot be compared.  ACSM’s data is an 
average of national VO2MAX for a 10 year age range.  Houmard et. al’s (1998) study 
closely matches the population in this study because it represents Eastern North 
Carolina’s VO2MAX values and eliminates the age gap represented in ACSM’s data.    
Although the subject’s VO2MAX were closely matched with another study (Houmard, 
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Weidner et al., 1998), only 2 subjects (MR002, MR003) had lower than normal values.  
However there was no significant difference when compared to pre-operation values.  
Treadmill times varied with individuals:  MR001 and MR005 had lower post-operation 
treadmill times, while the other two subjects MR002 and MR003 had higher post-
operation treadmill times.  Overall the mean treadmill time for the subjects were no 
different post-operation compared to pre-operation.  All subjects continued testing until 
they indicated they wanted the test to be terminated.  Also subjects reached their 60% 
heart rate max, which showed a true max for the patients in the current study.    
 There were a few factors that were controlled in this study.  First patients enrolled 
were already diagnosed with valvular disease, AF, or both.  Second, these patients were 
scheduled to have minimally invasive corrective surgery.  Lastly, patients were not to 
have a NYHA class of III or IV, thus causing them increased discomfort with stress 
testing.  Whether or not patients returned to their daily activities or if they exercised post-
surgery was not controlled.    
Effects of AF and MR on Exercise Tolerance 
 Severe AF and MR patients have reduced exercise tolerance and an inability to 
increase it due to the palpitations and fatigue associated with the disease (De Feo, 
Franceschini et al. 2005; Agostoni, Emdin et al. 2008).  Typically these patients cannot 
perform their usual daily activity, are greatly fatigued by minimal exertion, and have a 
severely reduced exercise tolerance (Agostoni, Emdin et al. 2008).  Compared to 
previous studies (Lewis, Irvine et al. 1988), the current subjects were asymptomatic and 
did not have a severe disease progression nor a severely reduced exercise tolerance.  
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Unlike previously treated patients that were in severe condition (Lewis, Irvine et al. 
1988), the current patients were still active and performing their daily activities with little 
to no help.  When compared to age predicted data with no signs of CHF or other known 
cardiac problem (Houmard, Weidner et al. 1998), there was no significant differences in 
VO2MAX.   
Effect of Minimally Invasive Sugery on Exercise Tolerance 
Studies have shown that Minimally Invasive Robotic Surgery does return a 
patient to normal sinus rhythm (Gammie, Laschinger et al., 2005; Gammie, Didolkar et 
al., 2009) and return a patient to their daily activities 2 weeks quicker than a normal 
sternotomy (Mohr, Onnasch et al., 1999; Reichenspurner, Boehm et al., 2000; Felger, 
Chitwood et al., 2001).  It has also been shown that treating MR and AF early, before the 
condition becomes severe enough to decrease an individual’s daily activities, can return 
the patient to a condition capable of increasing their exercise tolerance (Meurin, Iliou et 
al., 2005).  However, it is not known how soon surgical treatment should be given in MR 
and AF patients.  It is also unknown how soon improved exercise tolerance can be 
observed (with no training).   
Historically, exercise tolerance is reduced in AF and MR patients (De Feo, 
Franceschini et al., 2005; Agostoni, Emdin et al., 2008) and surgical treatment improves 
exercise tolerance (Le Tourneau, de Groote et al., 2000; Meurin, Iliou et al., 2005).  In 
AF and MR patients with reduced exercise tolerance, surgical intervention improved 
exercise tolerance by 11.2% at 4 mo post-surgery (Madaric, Watripont et al., 2007).  
When surgical treatment is followed with formal exercise training, peak oxygen 
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consumption and anaerobic threshold increased 22% and 16% respectively 8 weeks post 
surgery (Meurin, Iliou et al., 2005).  Compared to those results, the current study found 
that 7-11 weeks after surgery, with patients being sedentary, there was no difference in 
exercise capacity.     
Limitations 
 A limitation that could not be controlled was the time the patient was tested for 
their post-operative visit.  Because of scheduling patients coming from out of town and 
unseen factors such as illness, patient’s post-operative visits varied.  The post-operative 
visit was between 7-11 weeks post-surgery.  Three patients came in 7 weeks after surgery 
with one coming in 11 weeks after surgery.     
 Since all testing was done at Brody, there was a limitation with measuring body 
fat percentage.  Instead of using a Dual Energy X-Ray Absorptiometry (DEXA) to 
measure body fat, a 7-site skinfold was taken on the right side of every subject.  While 
the accuracy of predicting percent fat from skinfolds is approximately plus or minus 3.5% 
assuming that appropriate techniques and equations have been used (Medicine, 2005), 
DEXA has an accuracy of plus or minus 1-3%.      
Inexperience in treadmill usage was an issue for some patients.  Some patients felt 
very comfortable on the treadmill, keeping hands by their sides and swinging them; while 
others patients were not as accustomed to the incline of the machine and holding the side 
handle bars.  This could have biased exercise tolerance during the initial test toward 
lower exercise tolernace pre-surgery. 
Future Projects 
40 
 
 
 
In order for a stronger finding to occur, more subjects need to be recruited and 
tested.  Since the patients in this study were treated fairly early in their disease 
progression (NYHA classication Stage 1), a 6 month follow up in combination with an 
exercise training may demonstrate significant increases in VO2MAX.  If these patients 
underwent an exercise training program and follow up evaluations could be done, 
perhaps their VO2MAX would be higher. 
Conclusions 
At 7-11 weeks following minimally invasive surgery to treat MR and AF, 
exercise tolerance is unchanged compared to pre-surgery.  While not tested in the current 
investigation, it is likely that surgical treatment involving a sternocotomy would have 
decreased exercise tolerance at 7-11 weeks post-op suggesting that minimally invasive 
surgery does provide significant outcomes for patients by maintaining exercise tolerance.  
Historically, surgical treatment for MR and AF is associated with an improvement in 
exercise tolerance which was not observed in the current investigation, however when 
patients with MR and AF are tested early in disease progression (NYHA class I) there is 
no significant decrement in exercise tolerance compared to age normative data and so 
surgery would not be expected to improve exercise tolerance.  Since the patients in the 
current study were treated fairly early, they can return to daily activities quicker post 
surgery and they have the potential to increase their exercise tolerance and be above age 
normative data.  The results of this study do not support the hypothesis that subjects’ 
exercise capacity and tolerance will be reduced 7-11 weeks post-operation.  
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